US20010051827A1 - Cornea-supported artificial intraocular lens - Google Patents
Cornea-supported artificial intraocular lens Download PDFInfo
- Publication number
- US20010051827A1 US20010051827A1 US09/860,234 US86023401A US2001051827A1 US 20010051827 A1 US20010051827 A1 US 20010051827A1 US 86023401 A US86023401 A US 86023401A US 2001051827 A1 US2001051827 A1 US 2001051827A1
- Authority
- US
- United States
- Prior art keywords
- cornea
- intraocular lens
- artificial intraocular
- optical part
- supports
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000003287 optical effect Effects 0.000 claims abstract description 14
- -1 poly(methyl methacrylate) Polymers 0.000 claims abstract description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000000560 biocompatible material Substances 0.000 claims abstract description 6
- 229920003229 poly(methyl methacrylate) Polymers 0.000 claims abstract description 4
- 239000004926 polymethyl methacrylate Substances 0.000 claims abstract description 4
- 239000000377 silicon dioxide Substances 0.000 claims abstract description 3
- 239000011347 resin Substances 0.000 claims abstract 2
- 229920005989 resin Polymers 0.000 claims abstract 2
- 210000004087 cornea Anatomy 0.000 abstract description 22
- 210000001508 eye Anatomy 0.000 description 13
- 210000002159 anterior chamber Anatomy 0.000 description 6
- 239000007788 liquid Substances 0.000 description 5
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- 210000005252 bulbus oculi Anatomy 0.000 description 4
- 210000002889 endothelial cell Anatomy 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 238000010586 diagram Methods 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 210000001525 retina Anatomy 0.000 description 2
- 239000004925 Acrylic resin Substances 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 1
- 241000283977 Oryctolagus Species 0.000 description 1
- KCLANYCVBBTKTO-UHFFFAOYSA-N Proparacaine Chemical compound CCCOC1=CC=C(C(=O)OCCN(CC)CC)C=C1N KCLANYCVBBTKTO-UHFFFAOYSA-N 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000001949 anaesthesia Methods 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000004240 ciliary body Anatomy 0.000 description 1
- 210000000399 corneal endothelial cell Anatomy 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229960003299 ketamine Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229960003981 proparacaine Drugs 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- BPICBUSOMSTKRF-UHFFFAOYSA-N xylazine Chemical compound CC1=CC=CC(C)=C1NC1=NCCCS1 BPICBUSOMSTKRF-UHFFFAOYSA-N 0.000 description 1
- 229960001600 xylazine Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2/1613—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2/1602—Corrective lenses for use in addition to the natural lenses of the eyes or for pseudo-phakic eyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/142—Cornea, e.g. artificial corneae, keratoprostheses or corneal implants for repair of defective corneal tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/15—Implant having one or more holes, e.g. for nutrient transport, for facilitating handling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2002/1681—Intraocular lenses having supporting structure for lens, e.g. haptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
Definitions
- the present invention relates to an artificial intraocular lens attachable to the cornea, which shows a desirable refraction index and causes almost no complications.
- FIG. 1 there is shown an anatomy of the eye in a cross sectional view.
- incident light beams are refracted mainly in a cornea 1 and lens 5 to form a focus on a retina 9 as in a camera, allowing the human to see an image or a scene.
- the lens 5 cannot refract external light beams appropriately to form a focused image on the retina 9 , which corresponds to a film in a camera.
- Serious turbidity of the lens 6 may result in losing one's sight.
- the lens When the lens is turbid to such a serious extent as to cause blindness, it is replaced with an artificial lens to recover the sight.
- surgical insertion of an artificial lens in the eyeball is well known.
- the anterior chamber angle, the ciliary body, or capsular lentis is the place where an artificial lens is inserted.
- an artificial lens may be supported to the iris 3 .
- the tissues e.g. the iris
- an artificial lens is surgically transplanted to be supported by the iris
- the patient may suffer from a complication.
- the conventional sites in which an artificial lens is inserted are distant from the cornea, in which the greatest refraction of incident beams occurs, the actual refraction after the operation often does not agree with expected refraction.
- an artificial intraocular lens which is supportable to the cornea and made of a biocompatible material, comprising: an asymmetrical optical part; two supports extended from opposite sides of the optical part; and plate- or ring-shaped, fixing parts having at least one hole, positioned at terminal parts of the supports.
- FIG. 1 is a diagram showing the structure of the eye.
- FIG. 2 is a diagram showing the structure of the artificial, intraocular lens of the present invention.
- FIG. 3 is a diagram after the artificial, intraocular lens of the present invention is applied to the eye.
- the present invention pertains to an artificial intraocular lens that can increase the refraction of incident beams to a satisfactory level, be fixed firmly enough to prevent the occurrence of complications, and allow the liquid of anterior chamber to smoothly flow to prevent the damage of corneal endothelial cells.
- the artificial intraocular lens of the present invention is made of a biocompatible material.
- a biocompatible material is poly(methyl methacrylate), silica or acrylic resin. Since its biocompatibility as an ocular material through elution tests and biological assays in the 1940s, poly(methyl methacrylate) has been extensively used.
- the artificial intraocular lens comprises an asymmetrical optical part 1 a , two supports 1 b extended from opposite sides of the optical part 1 a , and plate- or ring-shaped, fixing parts 1 c having at least one hole 1 d , positioned at terminal parts of the supports 1 b .
- the asymmetrical design of the optical part 1 a is to allow the smooth covection current of the liquid of the anterior chamber.
- the optical part has a truncated circle shape.
- the supports 1 c are inserted to either the cornea or the parenchyma between the cornea and the corneosclera and fixed thereat, firmly supporting the artificial intraocular lens to the cornea.
- At least one hole 1 d is provided to the supports 1 c , playing a role in firmly fixing the supports 1 c to the cornea or the parenchyma between the cornea and the corneosclera.
- FIG. 3 shows the application of the artificial intraocular lens of the present invention to the eye.
- the artificial intraocular lens of the present invention is designed to be fixed to the cornea or the corneosclera, which contributes most to the refraction index of the eye, in addition to being an anatomically stable tissue, not only can incident beams be refracted to a desired angle, but only minimal complications, if any, occur.
- the optical part 1 a has an asymmetrical shape like a truncated circle, so that, when the artificial intraocular lens is applied to the eyeball, the liquid of the anterior chamber can flow smoothly without damage to the endothelial cells of the cornea.
- Ketamine and xylazine each were administered to New Zealand rabbits weighing about 3 kg at a dose of 50 mg/kg by intramuscular injection at the posterior. When no responses were obtained after irritation of eye rims of the rabbits, each of them was fixed on a board in which nails were previously driven according to a rabbit contour.
- 1% proparacaine was dropped in the eyes for complete anaesthesia, after which the eye rims were sterilized with a 10% providone solution.
- 6-0 black silk sutures were passed through the extraocular muscle of the eyes to fix the eyes.
- the cornea was opened, after which the artificial intraocular lens of the present invention was inserted into the opened site which was then sutured.
- the artificial intraocular lens of the present invention is fixed to the parenchyma of the cornea or the corneosclera, which contributes most of the refractive index of the eyeball and is an anatomically stable tissue, unlike the iris, such that there can be brought about effects of increasing the refraction of incident beams to a desirable level and minimizing post-operation complications.
- the asymmetrical shape of the artificial intraocular lens allows smooth covection of the liquid of the anterior chamber, preventing the endothelial cells of the cornea from being damaged.
- the holes provided to the supports serve to firmly fix the artificial intraocular lens to corneal parenchyma.
Landscapes
- Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
Abstract
Disclosed is an artificial intraocular lens attachable to the cornea. Made of a biocompatible material such as poly(methyl methacrylate), silica or acryl resin, the artificial intraocular lens comprises an asymmetrical optical part, two supports extended from opposite sides of the optical part; and plate- or ring-shaped, fixing parts having at least one hole, positioned at terminal parts of the supports.
Description
- The present invention relates to an artificial intraocular lens attachable to the cornea, which shows a desirable refraction index and causes almost no complications.
- In order to better understand the background of the present invention, a description will be given of the eye in conjunction with FIG. 1. With reference to FIG. 1, there is shown an anatomy of the eye in a cross sectional view. In the eye, incident light beams are refracted mainly in a cornea1 and lens 5 to form a focus on a
retina 9 as in a camera, allowing the human to see an image or a scene. When becoming turbid for congenital or acquired reasons, the lens 5 cannot refract external light beams appropriately to form a focused image on theretina 9, which corresponds to a film in a camera. Serious turbidity of the lens 6 may result in losing one's sight. - When the lens is turbid to such a serious extent as to cause blindness, it is replaced with an artificial lens to recover the sight. In this regard, surgical insertion of an artificial lens in the eyeball is well known. For example, the anterior chamber angle, the ciliary body, or capsular lentis is the place where an artificial lens is inserted. In addition, an artificial lens may be supported to the
iris 3. - However, some of the tissues, e.g. the iris, are anatomically so unstable that an artificial lens cannot be fixed thereto. For example, if an artificial lens is surgically transplanted to be supported by the iris, the patient may suffer from a complication. In addition, because the conventional sites in which an artificial lens is inserted are distant from the cornea, in which the greatest refraction of incident beams occurs, the actual refraction after the operation often does not agree with expected refraction.
- Therefore, it is an object of the present invention to overcome the above problems encountered in prior arts and to provide an artificial intraocular lens, which can be supported by the cornea.
- It is another object of the present invention to provide an artificial intraocular lens, which shows a desirable refraction index, can be firmly fixed to the cornea with little complications after surgical transplantation, and allows the liquid of the anterior chamber to flow so smoothly as to prevent the endothelial cells of the cornea from being damaged.
- Based on the present invention, the above objects of the present invention could be accomplished by a provision of an artificial intraocular lens, which is supportable to the cornea and made of a biocompatible material, comprising: an asymmetrical optical part; two supports extended from opposite sides of the optical part; and plate- or ring-shaped, fixing parts having at least one hole, positioned at terminal parts of the supports.
- FIG. 1 is a diagram showing the structure of the eye.
- FIG. 2 is a diagram showing the structure of the artificial, intraocular lens of the present invention.
- FIG. 3 is a diagram after the artificial, intraocular lens of the present invention is applied to the eye.
- The present invention pertains to an artificial intraocular lens that can increase the refraction of incident beams to a satisfactory level, be fixed firmly enough to prevent the occurrence of complications, and allow the liquid of anterior chamber to smoothly flow to prevent the damage of corneal endothelial cells.
- The artificial intraocular lens of the present invention is made of a biocompatible material. Suitable as such a biocompatible material is poly(methyl methacrylate), silica or acrylic resin. Since its biocompatibility as an ocular material through elution tests and biological assays in the 1940s, poly(methyl methacrylate) has been extensively used.
- With reference to FIG. 2, there is illustrated the artificial intraocular lens of the present invention. As seen in this figure, the artificial intraocular lens comprises an asymmetrical optical part1 a, two supports 1 b extended from opposite sides of the optical part 1 a, and plate- or ring-shaped, fixing parts 1 c having at least one hole 1 d, positioned at terminal parts of the supports 1 b. The asymmetrical design of the optical part 1 a is to allow the smooth covection current of the liquid of the anterior chamber. In detail, as seen in FIG. 2, the optical part has a truncated circle shape.
- To opposite sides of the intraocular lens optical part1 a are fixed two supports 1 b at terminal sites of which plate- or ring-shaped fixing parts 1 c are provided.
- The supports1 c are inserted to either the cornea or the parenchyma between the cornea and the corneosclera and fixed thereat, firmly supporting the artificial intraocular lens to the cornea.
- At least one hole1 d is provided to the supports 1 c, playing a role in firmly fixing the supports 1 c to the cornea or the parenchyma between the cornea and the corneosclera.
- After the supports1 c are inserted into the corneal parenchyma by a surgical operation, corneal cells can grow through the support holes 1 d, so that the optical part 1 c can be firmly fixed to the cornea or the parenchyma between the cornea and the corneosclera. FIG. 3 shows the application of the artificial intraocular lens of the present invention to the eye.
- Because the artificial intraocular lens of the present invention is designed to be fixed to the cornea or the corneosclera, which contributes most to the refraction index of the eye, in addition to being an anatomically stable tissue, not only can incident beams be refracted to a desired angle, but only minimal complications, if any, occur.
- Additionally, the optical part1 a has an asymmetrical shape like a truncated circle, so that, when the artificial intraocular lens is applied to the eyeball, the liquid of the anterior chamber can flow smoothly without damage to the endothelial cells of the cornea.
- A better understanding of the present invention may be obtained in light of the following examples which are set forth to illustrate, but are not to be construed to limit the present invention.
- Ketamine and xylazine each were administered to New Zealand rabbits weighing about 3 kg at a dose of 50 mg/kg by intramuscular injection at the posterior. When no responses were obtained after irritation of eye rims of the rabbits, each of them was fixed on a board in which nails were previously driven according to a rabbit contour.
- 1% proparacaine was dropped in the eyes for complete anaesthesia, after which the eye rims were sterilized with a 10% providone solution. 6-0 black silk sutures were passed through the extraocular muscle of the eyes to fix the eyes. Using a diamond dissector, the cornea was opened, after which the artificial intraocular lens of the present invention was inserted into the opened site which was then sutured.
- An observation was continuously made of the behavior of the rabbits for 7 days in a breeding room after they came out of the anesthetic. At one week, one month and three months after the operation, the eyeballs were removed from the rabbits and fixed in formalin. Microscopic observation of the eye tissue indicated that the artificial intraocular lens of the present invention was firmly fixed to the cornea and had generated no complications nor damage to the endothelial cells of the cornea.
- As described hereinbefore, the artificial intraocular lens of the present invention is fixed to the parenchyma of the cornea or the corneosclera, which contributes most of the refractive index of the eyeball and is an anatomically stable tissue, unlike the iris, such that there can be brought about effects of increasing the refraction of incident beams to a desirable level and minimizing post-operation complications. Additionally, the asymmetrical shape of the artificial intraocular lens allows smooth covection of the liquid of the anterior chamber, preventing the endothelial cells of the cornea from being damaged. Furthermore, the holes provided to the supports serve to firmly fix the artificial intraocular lens to corneal parenchyma.
- The present invention has been described in an illustrative manner, and it is to be understood that the terminology used is intended to be in the nature of description rather than of limitation. Many modifications and variations of the present invention are possible in light of the above teachings. Therefore, it is to be understood that within the scope of the appended claims, the invention may be practiced otherwise than as specifically described.
Claims (3)
1. A cornea-supported artificial intraocular lens, made of a biocompatible material, comprising:
an asymmetrical optical part;
two supports extended from opposite sides of the optical part; and
plate- or ring-shaped, fixing parts having at least one hole, positioned at terminal parts of the supports.
2. The cornea-supported, artificial intraocular lens as set forth in , wherein the biocompatible material is selected from the group consisting of poly(methyl methacrylate), silica, and acryl resin.
claim 1
3. The cornea-supported, artificial intraocular lens as set forth in , wherein the asymmetrical optical part has a truncated circular shape.
claim 1
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/306,099 US7175661B1 (en) | 2000-06-09 | 2002-11-27 | Apparatus and method for improving vision utilizing a cornea-supported artificial intraocular lens |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR2000-31581 | 2000-06-09 | ||
KR1020000031581A KR100345326B1 (en) | 2000-06-09 | 2000-06-09 | A corneal supported intraocular lens |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/306,099 Continuation-In-Part US7175661B1 (en) | 2000-06-09 | 2002-11-27 | Apparatus and method for improving vision utilizing a cornea-supported artificial intraocular lens |
Publications (1)
Publication Number | Publication Date |
---|---|
US20010051827A1 true US20010051827A1 (en) | 2001-12-13 |
Family
ID=19671482
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/860,234 Abandoned US20010051827A1 (en) | 2000-06-09 | 2001-05-18 | Cornea-supported artificial intraocular lens |
US10/306,099 Expired - Fee Related US7175661B1 (en) | 2000-06-09 | 2002-11-27 | Apparatus and method for improving vision utilizing a cornea-supported artificial intraocular lens |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/306,099 Expired - Fee Related US7175661B1 (en) | 2000-06-09 | 2002-11-27 | Apparatus and method for improving vision utilizing a cornea-supported artificial intraocular lens |
Country Status (2)
Country | Link |
---|---|
US (2) | US20010051827A1 (en) |
KR (1) | KR100345326B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2018532517A (en) * | 2015-11-09 | 2018-11-08 | Hoya株式会社 | Optical device with partial or incomplete optical element and related method |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1788982A4 (en) * | 2004-08-24 | 2007-12-26 | Vision Membrane Technologies I | Foldable intraocular lens with adaptable haptics |
US20090012507A1 (en) * | 2007-03-13 | 2009-01-08 | William Culbertson | Method for patterned plasma-mediated modification of the crystalline lens |
US8728158B2 (en) * | 2009-02-09 | 2014-05-20 | Jeffrey C. Whitsett | Exchangeable intraocular lens device and method of use |
EP2768431B1 (en) * | 2011-10-21 | 2018-02-21 | Endoshield, LLC | A corneal implant |
US9358102B2 (en) * | 2013-11-04 | 2016-06-07 | Visioncare Ophthalmic Technologies Inc. | Method and apparatus for preparation and insertion of an intraocular lens into the eye of a patient |
US10201415B2 (en) | 2013-11-04 | 2019-02-12 | Visioncare, Inc. | Method and apparatus for preparation and insertion of an intraocular lens into the eye of a patient |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4268921A (en) * | 1979-10-22 | 1981-05-26 | Kelman Charles D | Intraocular lenses |
US4451938A (en) * | 1982-09-24 | 1984-06-05 | Kelman Charles D | Intraocular lens and method of positioning the same in an eye |
GB2171912A (en) * | 1985-03-05 | 1986-09-10 | Charles William Simcoe | Hinged intraocular lens |
NL8900082A (en) * | 1989-01-13 | 1990-08-01 | Pharmacia Production B V | INTRA-OCULAR LENS. |
DE69414201T2 (en) * | 1993-07-28 | 1999-05-06 | Iolab Corp., Claremont, Calif. | Intraocular lens with unbreakable brackets |
US6342058B1 (en) * | 1999-05-14 | 2002-01-29 | Valdemar Portney | Iris fixated intraocular lens and instrument for attaching same to an iris |
US6478821B1 (en) * | 2000-01-12 | 2002-11-12 | Advanced Medical Optics, Inc. | Iris fixated intraocular lens and method of implantation |
US6482229B1 (en) * | 2000-11-21 | 2002-11-19 | Advanced Medical Optics, Inc. | Anterior chamber intraocular lens having fixation members attached to the cornea and methods of implantation |
-
2000
- 2000-06-09 KR KR1020000031581A patent/KR100345326B1/en not_active IP Right Cessation
-
2001
- 2001-05-18 US US09/860,234 patent/US20010051827A1/en not_active Abandoned
-
2002
- 2002-11-27 US US10/306,099 patent/US7175661B1/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2018532517A (en) * | 2015-11-09 | 2018-11-08 | Hoya株式会社 | Optical device with partial or incomplete optical element and related method |
Also Published As
Publication number | Publication date |
---|---|
KR100345326B1 (en) | 2002-07-24 |
US7175661B1 (en) | 2007-02-13 |
KR20010110894A (en) | 2001-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4734095A (en) | Self-centering artificial introaocular lens | |
US6241777B1 (en) | Phakic intraocular lenses | |
Lloyd et al. | Ocular biomaterials and implants | |
US4556998A (en) | Artificial intraocular lenses and method for their surgical implantation | |
JP5538420B2 (en) | Haptic device for intraocular lens | |
US4366582A (en) | Posterior chamber intraocular lens | |
US6261321B1 (en) | Phakic or aphakic intraocular lens assembly | |
JP4023829B2 (en) | Self-centering facick intraocular lens | |
US4485499A (en) | Intraocular posterior chamber lens | |
EP1196115B1 (en) | Positive power anterior chamber ocular implant | |
US4547914A (en) | Intraocular posterior chamber lens | |
US20010044657A1 (en) | Phakic or aphakic intraocular lens assembly | |
JPH0514580B2 (en) | ||
Barber | Keratoprostheses: past and present | |
Hicks et al. | Clinical results of implantation of the Chirila keratoprosthesis in rabbits | |
US20230190447A1 (en) | Implantable lens capsule for intraocular lens insertion | |
Packard et al. | Poly-HEMA as a material for intraocular lens implantation: a preliminary report. | |
US4547915A (en) | Intraocular posterior chamber lens | |
CN201782846U (en) | Artificial cornea | |
US20010051827A1 (en) | Cornea-supported artificial intraocular lens | |
Cook et al. | Clinical and pathologic evaluation of a flexible silicone posterior chamber lens design in a rabbit model | |
US20020120331A1 (en) | Refractive anterior chamber intraocular implant | |
GB2180160A (en) | Self-centering artificial intraocular lens | |
US20020120330A1 (en) | Refractive anterior chamber intraocular implant | |
RU86462U1 (en) | REAR CAMERA ELASTIC INTRAOCULAR LENS FOR AFACIA CORRECTION |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: CHUNG, YOUNG TAEK, KOREA, REPUBLIC OF Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CHUNG, YOUNG TAEK;LEE, MU SUK;AHN, BYUNG KI;REEL/FRAME:011933/0045 Effective date: 20010611 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |